Skip to main content

Advertisement

SpringerLink
Log in

A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups

  • Diabetes
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

We used a population based study in the Netherlands of 330 Hindustani Surinamese, 586 African Surinamese, and 486 ethnic Dutch (Dutch) to describe the prevalence of the metabolic syndrome (MS) and the association with differences in cardiovascular disease in and between ethnic groups. Fasting blood samples, blood pressure, and anthropometric measurements were obtained. MS was defined according to the criteria of the International Diabetes Federation (IDF) and the criteria of the National Cholesterol Education Program (NCEP). Cardiovascular disease was assessed by the Rose questionnaire and included questions on previous diagnoses of angina pectoris/myocardial infarction, cerebrovascular accident, intermittent claudication. The prevalence of MS (IDF and NCEP) was highest in Hindustani Surinamese men, followed by Dutch and African Surinamese men: 51.0%, 19.4%, and 31.2% (IDF), respectively. Among women, both the Hindustani and African Surinamese participants had a higher prevalence of MS (IDF and NCEP) than the Dutch. The association between the components, MS and cardiovascular disease differed between ethnic groups, in particular among men; OR for MS (NCEP) = 1.0 (0.4–2.7) among Hindustani Surinamese, OR = 4.9 (1.3–18.3) among African Surinamese, and OR = 2.8 (1.1–7.1) among Dutch. However, the differences in MS could not account for the ethnic differences in cardiovascular disease, regardless of the criteria used. The results suggest that, before the criteria can be used to guide practice, they may need to be changed and refined to take into account the differences between ethnic groups as well as the variations by gender.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  2. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in Hindustani Surinamese. Lancet 1991;337:382–6.

    Article  PubMed  CAS  Google Scholar 

  3. Gerstein HC, Anand SS, Yi QL, et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 2003;26:144–9.

    Article  PubMed  Google Scholar 

  4. Isomaa B, Almgren P, Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.

    Article  PubMed  CAS  Google Scholar 

  5. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 2002;25:829–34.

    Article  PubMed  Google Scholar 

  6. Anand SS, Yi QL, Gerstein HC, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003;29:420–5.

    Article  CAS  Google Scholar 

  7. Tillin T, Forouhi N, Johnston DG, et al. Metabolic syndrome and coronary heart disease in South Asians, Afro-Caribbeans and Dutch: a UK population-based cross sectional study. Diabetologia 2005;48:649–6.

    Article  PubMed  CAS  Google Scholar 

  8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.

    Google Scholar 

  9. World Health Organization, Department of Non-Communicable Disease Surveillance Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.

  10. Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003;26:1251–7.

    Article  PubMed  Google Scholar 

  11. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–16.

    Article  PubMed  Google Scholar 

  12. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–9.

    Article  PubMed  CAS  Google Scholar 

  13. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391–7.

    Article  PubMed  Google Scholar 

  14. Hu G, Qiao Q, Toumilehto J, Balkau B, Borch-Johsnen K, Pyorala K. DECODE Study Group Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004;164:1066–76.

    Article  PubMed  Google Scholar 

  15. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. San Antonio Heart Study National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251–7.

    Article  PubMed  Google Scholar 

  16. International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf. Accessed 16 Feb 2006

  17. Bindraban NR, Stronks K, Klazinga NS. Cardiovascular risk factors for Surinamese in the Netherlands: a literature review. Ned Tijdschr Geneeskd 2003;147:1591–4.

    PubMed  CAS  Google Scholar 

  18. Agyemang C, Bindraban N, Mairuhu G, van Montfrans G, Koopmans R, Stronks K. Prevalence, awareness, treatment, and control of hypertension among black Surinamese, South Asian Surinamese and white Dutch in Amsterdam, the Netherlands: the SUNSET study. J Hypertens 2005;23:1971–7.

    Article  PubMed  CAS  Google Scholar 

  19. Rose G. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645–58.

    PubMed  CAS  Google Scholar 

  20. Fornengo P, Bosio A, Epifani G, Pallisco O, Mancuso A, Pascale C. Prevalence of silent myocardial ischemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabet Med 2006;23:775–9.

    Article  PubMed  CAS  Google Scholar 

  21. Kharlip J, Naglieri R, Mitchell BD, Ryan KA, Donner TW. Screening for silent coronary heart disease in type 2 diabetes. Diabetes Care 2006;29:692–4.

    Article  PubMed  Google Scholar 

  22. Fischbacher CM, Bhopal R, Unwin N, White M, Alberti KG. The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol 2001;30:1009–16.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Social Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands

    N. R. Bindraban, I. G. M. van Valkengoed & K. Stronks

  2. Department of Internal Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    G. Mairuhu, F. Holleman, J. B. L. Hoekstra & R. P. Koopmans

  3. Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    N. R. Bindraban & R. W. Koster

Authors
  1. N. R. Bindraban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. G. M. van Valkengoed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Mairuhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. W. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Holleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. B. L. Hoekstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. P. Koopmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Stronks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Stronks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bindraban, N.R., van Valkengoed, I.G.M., Mairuhu, G. et al. A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups. Eur J Epidemiol 23, 37–44 (2008). https://doi.org/10.1007/s10654-007-9200-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-007-9200-8

Keywords

Search

Navigation